Abstract Backgrounds Glypican-3 (GPC3) has been reported as one of the most promising
serum markers for hepatocellular carcinoma (HCC), while several studies have conflicting …

Background and Aims The diagnostic value of serum GPC3 in patients with hepatocellular
carcinoma (HCC) remains controversial. Thus, we performed a systematic review and meta …

Introduction and aim. Serum glypican-3 (GPC3) has been explored as a non-invasive
biomarker of hepatocellular carcinoma (HCC). However, controversy remains on its …

Objective Many individual studies have evaluated the diagnostic efficiency of serum
glypican-3 (GPC-3) for diagnosing hepatocellular carcinoma (HCC), but the results have …

OBJECTIVE: The diagnostic val-ue of serum GPC3 levels in patients with hepatocellular
carcinoma (HCC) and liver cirrhosis remains controversial. Therefore, we performed a meta …

Objective. This review is to evaluate the diagnostic value of serum GPC3 for hepatocellular
carcinoma (HCC) due to conflicting results reported. Methods. NCBI PubMed and Embase …

Methods We enrolled 157 consecutive patients with newly diagnosed HCC and 156 patients
with liver cirrhosis (LC) as the control group. GPC3 plasma levels were measured using two …

Background Egypt has high incidence of hepatocellular carcinoma (HCC). This is due to
wide spread of hepatitis C virus (HCV) infection which is responsible for most of the cases of …

Background: Previous studies have evaluated the diagnostic value of serum glypican-3 in
patients with hepatocellular carcinoma. However, the results remain inconsistent and even …

Background Recently, a series of studies have been published to examine the possible
diagnostic and prognostic values of glypican-3 (GPC3) in liver cancer with conflicting results …